阅读说明：本技术 一种治疗石淋的药物组合物 (Medicine composition for treating urolithiasis ) 是由 韩汝斌 于 2019-09-27 设计创作，主要内容包括：本发明公开了一种治疗石淋的药物组合物,由以下原料组成：威灵仙60克-90克、鸡内金100克-300克、金钱草100克-200克、海金砂60克-100克、石韦100克-200克、滑石120克-200克、天台乌药60克-90克、黑木耳100克、石打穿100克-150克和炙甘草60克-90克。本发明能有效的治疗多种石淋的病症且对人体无副作用,对肾结石、输尿管结石和膀胱结石有很好的治疗效果。(the invention discloses a pharmaceutical composition for treating urolithiasis, which consists of the following raw materials: 60-90 g of clematis root, 100-300 g of chicken's gizzard-membrane, 100-200 g of desmodium, 60-100 g of lygodium spore, 100-200 g of pyrrosia lingua, 120-200 g of talcum, 60-90 g of lindera aggregata, 100 g of black fungus, 100-150 g of herba lysimachiae and 60-90 g of honey-fried licorice root. The traditional Chinese medicine composition can effectively treat various urolithiasis diseases, has no side effect on a human body, and has a good treatment effect on kidney stones, ureteral stones and vesical stones.)

1. The pharmaceutical composition for treating urolithiasis is characterized by comprising the following raw materials:

60-90 g of clematis root, 100-300 g of chicken's gizzard-membrane, 100-200 g of desmodium, 60-100 g of lygodium spore, 100-200 g of pyrrosia lingua, 120-200 g of talcum, 60-90 g of lindera aggregata, 100 g of black fungus, 100-150 g of herba lysimachiae and 60-90 g of honey-fried licorice root.

2. The pharmaceutical composition for treating urolithiasis as claimed in claim 1, wherein the pharmaceutical composition is prepared from the following raw materials:

60 g of clematis root, 100 g of chicken's gizzard-membrane, 100 g of desmodium, 60 g of climbing fern spore, 100 g of pyrrosia leaf, 120 g of talcum, 60 g of lindera aggregata, 100 g of black fungus, 100 g of herba lysimachiae and 60 g of honey-fried licorice root.

3. The pharmaceutical composition for treating urolithiasis as claimed in claim 1, wherein the pharmaceutical composition is prepared from the following raw materials:

80 g of clematis root, 200 g of chicken's gizzard-membrane, 150 g of desmodium, 80 g of climbing fern spore, 150 g of pyrrosia leaf, 150 g of talcum, 70 g of lindera aggregata, 100 g of black fungus, 120 g of herba lysimachiae and 80 g of honey-fried licorice root.

4. The pharmaceutical composition for treating urolithiasis as claimed in claim 1, wherein the pharmaceutical composition is prepared from the following raw materials:

clematis root 90 g, chicken's gizzard-membrane 300 g, lysimachia christinae 200 g, climbing fern spore 100 g, pyrrosia leaf 200 g, talcum 200 g, lindera aggregata 90 g, black fungus 100 g, herba lysimachiae and honey-fried licorice root 90 g.

5. The pharmaceutical composition for treating urolithiasis as claimed in claim 1, 2, 3 or 4, wherein the pharmaceutical composition further comprises corydalis tuber 90 g-150 g.

6. The pharmaceutical composition for treating urolithiasis as claimed in claim 1, 2, 3 or 4, wherein said pharmaceutical composition is a powder having an average particle size of 160 mesh.

Technical Field

the invention belongs to the field of pharmaceutical compositions, and particularly relates to a pharmaceutical composition for treating urolithiasis.

Background

Urolithiasis, famous names, painful urination, and urine with stones; also known as sand stranguria or sand and stone stranguria. It is usually caused by heat accumulation in the lower energizer and water retention. For stranguria with stone, it can cause stones to appear. Kidneys govern water, which is transformed into stone, so kidneys control sand. Kidney deficiency is the cause of heat, and heat is the cause of stranguria. The pathological condition is pain in the stem of the urine, failure of urine to flow out, pain in the lower abdomen, urgency in the bladder, and sand coming out of the urinary tract, even obstruction, pain and oppression. At present, most of the drugs for treating urolithiasis can only treat one of the symptoms. When urolithiasis occurs, a plurality of symptoms are often accompanied, and a plurality of pharmaceutical compositions are needed to treat the symptoms. In this way, the physical burden on the patient is increased. In addition, many existing medicines for treating urolithiasis only have the effect of relieving symptoms, but are difficult to cure effectively. Therefore, there is a need for a pharmaceutical composition that is effective in treating a variety of urolithic conditions while also reducing the burden on the patient's body.

Disclosure of Invention

The technical problem to be solved by the invention is to provide a pharmaceutical composition for treating urolithiasis, which can effectively treat a plurality of urolithiasis symptoms without side effects on human bodies and has good treatment effects on kidney stones, ureteral stones and vesical stones.

The technical scheme adopted by the invention is as follows: a pharmaceutical composition for treating urolithiasis comprises the following raw materials:

60-90 g of clematis root, 100-300 g of chicken's gizzard-membrane, 100-200 g of desmodium, 60-100 g of lygodium spore, 100-200 g of pyrrosia lingua, 120-200 g of talcum, 60-90 g of lindera aggregata, 100 g of black fungus, 100-150 g of herba lysimachiae and 60-90 g of honey-fried licorice root.

In one embodiment, the material comprises the following raw materials:

60 g of clematis root, 100 g of chicken's gizzard-membrane, 100 g of desmodium, 60 g of climbing fern spore, 100 g of pyrrosia leaf, 120 g of talcum, 60 g of lindera aggregata, 100 g of black fungus, 100 g of herba lysimachiae and 60 g of honey-fried licorice root.

In one embodiment, the material comprises the following raw materials:

80 g of clematis root, 200 g of chicken's gizzard-membrane, 150 g of desmodium, 80 g of climbing fern spore, 150 g of pyrrosia leaf, 150 g of talcum, 70 g of lindera aggregata, 100 g of black fungus, 120 g of herba lysimachiae and 80 g of honey-fried licorice root.

In one embodiment, the material comprises the following raw materials:

Clematis root 90 g, chicken's gizzard-membrane 300 g, lysimachia christinae 200 g, climbing fern spore 100 g, pyrrosia leaf 200 g, talcum 200 g, lindera aggregata 90 g, black fungus 100 g, herba lysimachiae and honey-fried licorice root 90 g.

In one embodiment, the pharmaceutical composition can further comprise corydalis tuber 90 g-150 g.

in one embodiment, the pharmaceutical composition is a powder having an average particle size of 160 mesh.

The invention has the beneficial effects that: can effectively treat a plurality of stranguria with no side effect on human body, has good treatment effect on kidney stone, ureteral stone and vesical stone, and has certain effect on other stranguria with urinary stone.

Detailed Description

The present invention will be described in further detail with reference to specific examples.